Global FIC Drugs Market Growth 2026-2032
The global FIC Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
FIC (First in Class) refers to a drug that is first-in-class and is created by gradually synthesizing candidate compounds from scratch by finding new drug targets, mechanisms of action, and molecular structures. Through repeated trials and screening, the drug is ultimately found to meet the requirements of both therapeutic effects and human safety (tolerance, pharmacokinetics).
United States market for FIC Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for FIC Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for FIC Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key FIC Drugs players cover Pfizer, Johnson & Johnson, Merck, Roche, Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?FIC Drugs Industry Forecast? looks at past sales and reviews total world FIC Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected FIC Drugs sales for 2026 through 2032. With FIC Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world FIC Drugs industry.
This Insight Report provides a comprehensive analysis of the global FIC Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on FIC Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global FIC Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for FIC Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global FIC Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of FIC Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global FIC Drugs market?
What factors are driving FIC Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do FIC Drugs market opportunities vary by end market size?
How does FIC Drugs break out by Type, by Application?
FIC (First in Class) refers to a drug that is first-in-class and is created by gradually synthesizing candidate compounds from scratch by finding new drug targets, mechanisms of action, and molecular structures. Through repeated trials and screening, the drug is ultimately found to meet the requirements of both therapeutic effects and human safety (tolerance, pharmacokinetics).
United States market for FIC Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for FIC Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for FIC Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key FIC Drugs players cover Pfizer, Johnson & Johnson, Merck, Roche, Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?FIC Drugs Industry Forecast? looks at past sales and reviews total world FIC Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected FIC Drugs sales for 2026 through 2032. With FIC Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world FIC Drugs industry.
This Insight Report provides a comprehensive analysis of the global FIC Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on FIC Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global FIC Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for FIC Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global FIC Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of FIC Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- FIC Single-target Drugs
- FIC Dual-target Drugs
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Johnson & Johnson
- Merck
- Roche
- Novartis
- BMS
- ImmunoGen
- Sanofi
- Immunocore
- Genentech
- Eli Lilly
- Agios
- Boehringer Ingelheim
- Gilead
- Mallinckrodt
- Phathom
- Dermavant Sciences
- Polarean lmaging
- Marinus
What is the 10-year outlook for the global FIC Drugs market?
What factors are driving FIC Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do FIC Drugs market opportunities vary by end market size?
How does FIC Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global FIC Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for FIC Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for FIC Drugs by Country/Region, 2021, 2025 & 2032
2.2 FIC Drugs Segment by Type
2.2.1 FIC Single-target Drugs
2.2.2 FIC Dual-target Drugs
2.2.3 FIC Drugs Sales by Type
2.2.3.1 Global FIC Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global FIC Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global FIC Drugs Sale Price by Type (2021-2026)
2.3 FIC Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 FIC Drugs Sales by Application
2.3.4.1 Global FIC Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global FIC Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global FIC Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global FIC Drugs Breakdown Data by Company
3.1.1 Global FIC Drugs Annual Sales by Company (2021-2026)
3.1.2 Global FIC Drugs Sales Market Share by Company (2021-2026)
3.2 Global FIC Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global FIC Drugs Revenue by Company (2021-2026)
3.2.2 Global FIC Drugs Revenue Market Share by Company (2021-2026)
3.3 Global FIC Drugs Sale Price by Company
3.4 Key Manufacturers FIC Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers FIC Drugs Product Location Distribution
3.4.2 Players FIC Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FIC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic FIC Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global FIC Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global FIC Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic FIC Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global FIC Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global FIC Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas FIC Drugs Sales Growth
4.4 APAC FIC Drugs Sales Growth
4.5 Europe FIC Drugs Sales Growth
4.6 Middle East & Africa FIC Drugs Sales Growth
5 AMERICAS
5.1 Americas FIC Drugs Sales by Country
5.1.1 Americas FIC Drugs Sales by Country (2021-2026)
5.1.2 Americas FIC Drugs Revenue by Country (2021-2026)
5.2 Americas FIC Drugs Sales by Type (2021-2026)
5.3 Americas FIC Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC FIC Drugs Sales by Region
6.1.1 APAC FIC Drugs Sales by Region (2021-2026)
6.1.2 APAC FIC Drugs Revenue by Region (2021-2026)
6.2 APAC FIC Drugs Sales by Type (2021-2026)
6.3 APAC FIC Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe FIC Drugs by Country
7.1.1 Europe FIC Drugs Sales by Country (2021-2026)
7.1.2 Europe FIC Drugs Revenue by Country (2021-2026)
7.2 Europe FIC Drugs Sales by Type (2021-2026)
7.3 Europe FIC Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa FIC Drugs by Country
8.1.1 Middle East & Africa FIC Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa FIC Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa FIC Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa FIC Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of FIC Drugs
10.3 Manufacturing Process Analysis of FIC Drugs
10.4 Industry Chain Structure of FIC Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 FIC Drugs Distributors
11.3 FIC Drugs Customer
12 WORLD FORECAST REVIEW FOR FIC DRUGS BY GEOGRAPHIC REGION
12.1 Global FIC Drugs Market Size Forecast by Region
12.1.1 Global FIC Drugs Forecast by Region (2027-2032)
12.1.2 Global FIC Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global FIC Drugs Forecast by Type (2027-2032)
12.7 Global FIC Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer FIC Drugs Product Portfolios and Specifications
13.1.3 Pfizer FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson FIC Drugs Product Portfolios and Specifications
13.2.3 Johnson & Johnson FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck FIC Drugs Product Portfolios and Specifications
13.3.3 Merck FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche FIC Drugs Product Portfolios and Specifications
13.4.3 Roche FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis FIC Drugs Product Portfolios and Specifications
13.5.3 Novartis FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 BMS
13.6.1 BMS Company Information
13.6.2 BMS FIC Drugs Product Portfolios and Specifications
13.6.3 BMS FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 BMS Main Business Overview
13.6.5 BMS Latest Developments
13.7 ImmunoGen
13.7.1 ImmunoGen Company Information
13.7.2 ImmunoGen FIC Drugs Product Portfolios and Specifications
13.7.3 ImmunoGen FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ImmunoGen Main Business Overview
13.7.5 ImmunoGen Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi FIC Drugs Product Portfolios and Specifications
13.8.3 Sanofi FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Immunocore
13.9.1 Immunocore Company Information
13.9.2 Immunocore FIC Drugs Product Portfolios and Specifications
13.9.3 Immunocore FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Immunocore Main Business Overview
13.9.5 Immunocore Latest Developments
13.10 Genentech
13.10.1 Genentech Company Information
13.10.2 Genentech FIC Drugs Product Portfolios and Specifications
13.10.3 Genentech FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Genentech Main Business Overview
13.10.5 Genentech Latest Developments
13.11 Eli Lilly
13.11.1 Eli Lilly Company Information
13.11.2 Eli Lilly FIC Drugs Product Portfolios and Specifications
13.11.3 Eli Lilly FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Eli Lilly Main Business Overview
13.11.5 Eli Lilly Latest Developments
13.12 Agios
13.12.1 Agios Company Information
13.12.2 Agios FIC Drugs Product Portfolios and Specifications
13.12.3 Agios FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Agios Main Business Overview
13.12.5 Agios Latest Developments
13.13 Boehringer Ingelheim
13.13.1 Boehringer Ingelheim Company Information
13.13.2 Boehringer Ingelheim FIC Drugs Product Portfolios and Specifications
13.13.3 Boehringer Ingelheim FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Boehringer Ingelheim Main Business Overview
13.13.5 Boehringer Ingelheim Latest Developments
13.14 Gilead
13.14.1 Gilead Company Information
13.14.2 Gilead FIC Drugs Product Portfolios and Specifications
13.14.3 Gilead FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Gilead Main Business Overview
13.14.5 Gilead Latest Developments
13.15 Mallinckrodt
13.15.1 Mallinckrodt Company Information
13.15.2 Mallinckrodt FIC Drugs Product Portfolios and Specifications
13.15.3 Mallinckrodt FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Mallinckrodt Main Business Overview
13.15.5 Mallinckrodt Latest Developments
13.16 Phathom
13.16.1 Phathom Company Information
13.16.2 Phathom FIC Drugs Product Portfolios and Specifications
13.16.3 Phathom FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Phathom Main Business Overview
13.16.5 Phathom Latest Developments
13.17 Dermavant Sciences
13.17.1 Dermavant Sciences Company Information
13.17.2 Dermavant Sciences FIC Drugs Product Portfolios and Specifications
13.17.3 Dermavant Sciences FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Dermavant Sciences Main Business Overview
13.17.5 Dermavant Sciences Latest Developments
13.18 Polarean lmaging
13.18.1 Polarean lmaging Company Information
13.18.2 Polarean lmaging FIC Drugs Product Portfolios and Specifications
13.18.3 Polarean lmaging FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Polarean lmaging Main Business Overview
13.18.5 Polarean lmaging Latest Developments
13.19 Marinus
13.19.1 Marinus Company Information
13.19.2 Marinus FIC Drugs Product Portfolios and Specifications
13.19.3 Marinus FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Marinus Main Business Overview
13.19.5 Marinus Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global FIC Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for FIC Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for FIC Drugs by Country/Region, 2021, 2025 & 2032
2.2 FIC Drugs Segment by Type
2.2.1 FIC Single-target Drugs
2.2.2 FIC Dual-target Drugs
2.2.3 FIC Drugs Sales by Type
2.2.3.1 Global FIC Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global FIC Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global FIC Drugs Sale Price by Type (2021-2026)
2.3 FIC Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 FIC Drugs Sales by Application
2.3.4.1 Global FIC Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global FIC Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global FIC Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global FIC Drugs Breakdown Data by Company
3.1.1 Global FIC Drugs Annual Sales by Company (2021-2026)
3.1.2 Global FIC Drugs Sales Market Share by Company (2021-2026)
3.2 Global FIC Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global FIC Drugs Revenue by Company (2021-2026)
3.2.2 Global FIC Drugs Revenue Market Share by Company (2021-2026)
3.3 Global FIC Drugs Sale Price by Company
3.4 Key Manufacturers FIC Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers FIC Drugs Product Location Distribution
3.4.2 Players FIC Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FIC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic FIC Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global FIC Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global FIC Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic FIC Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global FIC Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global FIC Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas FIC Drugs Sales Growth
4.4 APAC FIC Drugs Sales Growth
4.5 Europe FIC Drugs Sales Growth
4.6 Middle East & Africa FIC Drugs Sales Growth
5 AMERICAS
5.1 Americas FIC Drugs Sales by Country
5.1.1 Americas FIC Drugs Sales by Country (2021-2026)
5.1.2 Americas FIC Drugs Revenue by Country (2021-2026)
5.2 Americas FIC Drugs Sales by Type (2021-2026)
5.3 Americas FIC Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC FIC Drugs Sales by Region
6.1.1 APAC FIC Drugs Sales by Region (2021-2026)
6.1.2 APAC FIC Drugs Revenue by Region (2021-2026)
6.2 APAC FIC Drugs Sales by Type (2021-2026)
6.3 APAC FIC Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe FIC Drugs by Country
7.1.1 Europe FIC Drugs Sales by Country (2021-2026)
7.1.2 Europe FIC Drugs Revenue by Country (2021-2026)
7.2 Europe FIC Drugs Sales by Type (2021-2026)
7.3 Europe FIC Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa FIC Drugs by Country
8.1.1 Middle East & Africa FIC Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa FIC Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa FIC Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa FIC Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of FIC Drugs
10.3 Manufacturing Process Analysis of FIC Drugs
10.4 Industry Chain Structure of FIC Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 FIC Drugs Distributors
11.3 FIC Drugs Customer
12 WORLD FORECAST REVIEW FOR FIC DRUGS BY GEOGRAPHIC REGION
12.1 Global FIC Drugs Market Size Forecast by Region
12.1.1 Global FIC Drugs Forecast by Region (2027-2032)
12.1.2 Global FIC Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global FIC Drugs Forecast by Type (2027-2032)
12.7 Global FIC Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer FIC Drugs Product Portfolios and Specifications
13.1.3 Pfizer FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson FIC Drugs Product Portfolios and Specifications
13.2.3 Johnson & Johnson FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck FIC Drugs Product Portfolios and Specifications
13.3.3 Merck FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche FIC Drugs Product Portfolios and Specifications
13.4.3 Roche FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis FIC Drugs Product Portfolios and Specifications
13.5.3 Novartis FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 BMS
13.6.1 BMS Company Information
13.6.2 BMS FIC Drugs Product Portfolios and Specifications
13.6.3 BMS FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 BMS Main Business Overview
13.6.5 BMS Latest Developments
13.7 ImmunoGen
13.7.1 ImmunoGen Company Information
13.7.2 ImmunoGen FIC Drugs Product Portfolios and Specifications
13.7.3 ImmunoGen FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ImmunoGen Main Business Overview
13.7.5 ImmunoGen Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi FIC Drugs Product Portfolios and Specifications
13.8.3 Sanofi FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Immunocore
13.9.1 Immunocore Company Information
13.9.2 Immunocore FIC Drugs Product Portfolios and Specifications
13.9.3 Immunocore FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Immunocore Main Business Overview
13.9.5 Immunocore Latest Developments
13.10 Genentech
13.10.1 Genentech Company Information
13.10.2 Genentech FIC Drugs Product Portfolios and Specifications
13.10.3 Genentech FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Genentech Main Business Overview
13.10.5 Genentech Latest Developments
13.11 Eli Lilly
13.11.1 Eli Lilly Company Information
13.11.2 Eli Lilly FIC Drugs Product Portfolios and Specifications
13.11.3 Eli Lilly FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Eli Lilly Main Business Overview
13.11.5 Eli Lilly Latest Developments
13.12 Agios
13.12.1 Agios Company Information
13.12.2 Agios FIC Drugs Product Portfolios and Specifications
13.12.3 Agios FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Agios Main Business Overview
13.12.5 Agios Latest Developments
13.13 Boehringer Ingelheim
13.13.1 Boehringer Ingelheim Company Information
13.13.2 Boehringer Ingelheim FIC Drugs Product Portfolios and Specifications
13.13.3 Boehringer Ingelheim FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Boehringer Ingelheim Main Business Overview
13.13.5 Boehringer Ingelheim Latest Developments
13.14 Gilead
13.14.1 Gilead Company Information
13.14.2 Gilead FIC Drugs Product Portfolios and Specifications
13.14.3 Gilead FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Gilead Main Business Overview
13.14.5 Gilead Latest Developments
13.15 Mallinckrodt
13.15.1 Mallinckrodt Company Information
13.15.2 Mallinckrodt FIC Drugs Product Portfolios and Specifications
13.15.3 Mallinckrodt FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Mallinckrodt Main Business Overview
13.15.5 Mallinckrodt Latest Developments
13.16 Phathom
13.16.1 Phathom Company Information
13.16.2 Phathom FIC Drugs Product Portfolios and Specifications
13.16.3 Phathom FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Phathom Main Business Overview
13.16.5 Phathom Latest Developments
13.17 Dermavant Sciences
13.17.1 Dermavant Sciences Company Information
13.17.2 Dermavant Sciences FIC Drugs Product Portfolios and Specifications
13.17.3 Dermavant Sciences FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Dermavant Sciences Main Business Overview
13.17.5 Dermavant Sciences Latest Developments
13.18 Polarean lmaging
13.18.1 Polarean lmaging Company Information
13.18.2 Polarean lmaging FIC Drugs Product Portfolios and Specifications
13.18.3 Polarean lmaging FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Polarean lmaging Main Business Overview
13.18.5 Polarean lmaging Latest Developments
13.19 Marinus
13.19.1 Marinus Company Information
13.19.2 Marinus FIC Drugs Product Portfolios and Specifications
13.19.3 Marinus FIC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Marinus Main Business Overview
13.19.5 Marinus Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. FIC Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. FIC Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of FIC Single-target Drugs
Table 4. Major Players of FIC Dual-target Drugs
Table 5. Global FIC Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global FIC Drugs Sales Market Share by Type (2021-2026)
Table 7. Global FIC Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global FIC Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global FIC Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global FIC Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global FIC Drugs Sale Market Share by Application (2021-2026)
Table 12. Global FIC Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global FIC Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global FIC Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global FIC Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global FIC Drugs Sales Market Share by Company (2021-2026)
Table 17. Global FIC Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global FIC Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global FIC Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers FIC Drugs Producing Area Distribution and Sales Area
Table 21. Players FIC Drugs Products Offered
Table 22. FIC Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global FIC Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global FIC Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global FIC Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global FIC Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global FIC Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global FIC Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global FIC Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global FIC Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas FIC Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas FIC Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas FIC Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas FIC Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas FIC Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC FIC Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC FIC Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC FIC Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC FIC Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC FIC Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe FIC Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe FIC Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe FIC Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe FIC Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa FIC Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa FIC Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa FIC Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa FIC Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of FIC Drugs
Table 52. Key Market Challenges & Risks of FIC Drugs
Table 53. Key Industry Trends of FIC Drugs
Table 54. FIC Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. FIC Drugs Distributors List
Table 57. FIC Drugs Customer List
Table 58. Global FIC Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global FIC Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas FIC Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas FIC Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC FIC Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC FIC Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe FIC Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe FIC Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa FIC Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa FIC Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global FIC Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global FIC Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global FIC Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global FIC Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Pfizer Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer FIC Drugs Product Portfolios and Specifications
Table 74. Pfizer FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. Johnson & Johnson Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Johnson & Johnson FIC Drugs Product Portfolios and Specifications
Table 79. Johnson & Johnson FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Johnson & Johnson Main Business
Table 81. Johnson & Johnson Latest Developments
Table 82. Merck Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck FIC Drugs Product Portfolios and Specifications
Table 84. Merck FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Roche Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Roche FIC Drugs Product Portfolios and Specifications
Table 89. Roche FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Roche Main Business
Table 91. Roche Latest Developments
Table 92. Novartis Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Novartis FIC Drugs Product Portfolios and Specifications
Table 94. Novartis FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Novartis Main Business
Table 96. Novartis Latest Developments
Table 97. BMS Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. BMS FIC Drugs Product Portfolios and Specifications
Table 99. BMS FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. BMS Main Business
Table 101. BMS Latest Developments
Table 102. ImmunoGen Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. ImmunoGen FIC Drugs Product Portfolios and Specifications
Table 104. ImmunoGen FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. ImmunoGen Main Business
Table 106. ImmunoGen Latest Developments
Table 107. Sanofi Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Sanofi FIC Drugs Product Portfolios and Specifications
Table 109. Sanofi FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Sanofi Main Business
Table 111. Sanofi Latest Developments
Table 112. Immunocore Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Immunocore FIC Drugs Product Portfolios and Specifications
Table 114. Immunocore FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Immunocore Main Business
Table 116. Immunocore Latest Developments
Table 117. Genentech Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Genentech FIC Drugs Product Portfolios and Specifications
Table 119. Genentech FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Genentech Main Business
Table 121. Genentech Latest Developments
Table 122. Eli Lilly Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Eli Lilly FIC Drugs Product Portfolios and Specifications
Table 124. Eli Lilly FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Eli Lilly Main Business
Table 126. Eli Lilly Latest Developments
Table 127. Agios Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Agios FIC Drugs Product Portfolios and Specifications
Table 129. Agios FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Agios Main Business
Table 131. Agios Latest Developments
Table 132. Boehringer Ingelheim Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Boehringer Ingelheim FIC Drugs Product Portfolios and Specifications
Table 134. Boehringer Ingelheim FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Boehringer Ingelheim Main Business
Table 136. Boehringer Ingelheim Latest Developments
Table 137. Gilead Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Gilead FIC Drugs Product Portfolios and Specifications
Table 139. Gilead FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Gilead Main Business
Table 141. Gilead Latest Developments
Table 142. Mallinckrodt Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. Mallinckrodt FIC Drugs Product Portfolios and Specifications
Table 144. Mallinckrodt FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Mallinckrodt Main Business
Table 146. Mallinckrodt Latest Developments
Table 147. Phathom Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. Phathom FIC Drugs Product Portfolios and Specifications
Table 149. Phathom FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Phathom Main Business
Table 151. Phathom Latest Developments
Table 152. Dermavant Sciences Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Dermavant Sciences FIC Drugs Product Portfolios and Specifications
Table 154. Dermavant Sciences FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Dermavant Sciences Main Business
Table 156. Dermavant Sciences Latest Developments
Table 157. Polarean lmaging Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Polarean lmaging FIC Drugs Product Portfolios and Specifications
Table 159. Polarean lmaging FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Polarean lmaging Main Business
Table 161. Polarean lmaging Latest Developments
Table 162. Marinus Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Marinus FIC Drugs Product Portfolios and Specifications
Table 164. Marinus FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Marinus Main Business
Table 166. Marinus Latest Developments
Table 1. FIC Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. FIC Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of FIC Single-target Drugs
Table 4. Major Players of FIC Dual-target Drugs
Table 5. Global FIC Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global FIC Drugs Sales Market Share by Type (2021-2026)
Table 7. Global FIC Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global FIC Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global FIC Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global FIC Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global FIC Drugs Sale Market Share by Application (2021-2026)
Table 12. Global FIC Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global FIC Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global FIC Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global FIC Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global FIC Drugs Sales Market Share by Company (2021-2026)
Table 17. Global FIC Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global FIC Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global FIC Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers FIC Drugs Producing Area Distribution and Sales Area
Table 21. Players FIC Drugs Products Offered
Table 22. FIC Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global FIC Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global FIC Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global FIC Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global FIC Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global FIC Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global FIC Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global FIC Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global FIC Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas FIC Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas FIC Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas FIC Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas FIC Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas FIC Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC FIC Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC FIC Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC FIC Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC FIC Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC FIC Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe FIC Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe FIC Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe FIC Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe FIC Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa FIC Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa FIC Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa FIC Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa FIC Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of FIC Drugs
Table 52. Key Market Challenges & Risks of FIC Drugs
Table 53. Key Industry Trends of FIC Drugs
Table 54. FIC Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. FIC Drugs Distributors List
Table 57. FIC Drugs Customer List
Table 58. Global FIC Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global FIC Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas FIC Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas FIC Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC FIC Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC FIC Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe FIC Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe FIC Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa FIC Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa FIC Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global FIC Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global FIC Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global FIC Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global FIC Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Pfizer Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer FIC Drugs Product Portfolios and Specifications
Table 74. Pfizer FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. Johnson & Johnson Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Johnson & Johnson FIC Drugs Product Portfolios and Specifications
Table 79. Johnson & Johnson FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Johnson & Johnson Main Business
Table 81. Johnson & Johnson Latest Developments
Table 82. Merck Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck FIC Drugs Product Portfolios and Specifications
Table 84. Merck FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Roche Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Roche FIC Drugs Product Portfolios and Specifications
Table 89. Roche FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Roche Main Business
Table 91. Roche Latest Developments
Table 92. Novartis Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Novartis FIC Drugs Product Portfolios and Specifications
Table 94. Novartis FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Novartis Main Business
Table 96. Novartis Latest Developments
Table 97. BMS Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. BMS FIC Drugs Product Portfolios and Specifications
Table 99. BMS FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. BMS Main Business
Table 101. BMS Latest Developments
Table 102. ImmunoGen Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. ImmunoGen FIC Drugs Product Portfolios and Specifications
Table 104. ImmunoGen FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. ImmunoGen Main Business
Table 106. ImmunoGen Latest Developments
Table 107. Sanofi Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Sanofi FIC Drugs Product Portfolios and Specifications
Table 109. Sanofi FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Sanofi Main Business
Table 111. Sanofi Latest Developments
Table 112. Immunocore Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Immunocore FIC Drugs Product Portfolios and Specifications
Table 114. Immunocore FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Immunocore Main Business
Table 116. Immunocore Latest Developments
Table 117. Genentech Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Genentech FIC Drugs Product Portfolios and Specifications
Table 119. Genentech FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Genentech Main Business
Table 121. Genentech Latest Developments
Table 122. Eli Lilly Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Eli Lilly FIC Drugs Product Portfolios and Specifications
Table 124. Eli Lilly FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Eli Lilly Main Business
Table 126. Eli Lilly Latest Developments
Table 127. Agios Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Agios FIC Drugs Product Portfolios and Specifications
Table 129. Agios FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Agios Main Business
Table 131. Agios Latest Developments
Table 132. Boehringer Ingelheim Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Boehringer Ingelheim FIC Drugs Product Portfolios and Specifications
Table 134. Boehringer Ingelheim FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Boehringer Ingelheim Main Business
Table 136. Boehringer Ingelheim Latest Developments
Table 137. Gilead Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Gilead FIC Drugs Product Portfolios and Specifications
Table 139. Gilead FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Gilead Main Business
Table 141. Gilead Latest Developments
Table 142. Mallinckrodt Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. Mallinckrodt FIC Drugs Product Portfolios and Specifications
Table 144. Mallinckrodt FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Mallinckrodt Main Business
Table 146. Mallinckrodt Latest Developments
Table 147. Phathom Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. Phathom FIC Drugs Product Portfolios and Specifications
Table 149. Phathom FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Phathom Main Business
Table 151. Phathom Latest Developments
Table 152. Dermavant Sciences Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Dermavant Sciences FIC Drugs Product Portfolios and Specifications
Table 154. Dermavant Sciences FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Dermavant Sciences Main Business
Table 156. Dermavant Sciences Latest Developments
Table 157. Polarean lmaging Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Polarean lmaging FIC Drugs Product Portfolios and Specifications
Table 159. Polarean lmaging FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Polarean lmaging Main Business
Table 161. Polarean lmaging Latest Developments
Table 162. Marinus Basic Information, FIC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Marinus FIC Drugs Product Portfolios and Specifications
Table 164. Marinus FIC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Marinus Main Business
Table 166. Marinus Latest Developments
LIST OF FIGURES
Figure 1. Picture of FIC Drugs
Figure 2. FIC Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global FIC Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global FIC Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. FIC Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. FIC Drugs Sales Market Share by Country/Region (2025)
Figure 10. FIC Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of FIC Single-target Drugs
Figure 12. Product Picture of FIC Dual-target Drugs
Figure 13. Global FIC Drugs Sales Market Share by Type in 2026
Figure 14. Global FIC Drugs Revenue Market Share by Type (2021-2026)
Figure 15. FIC Drugs Consumed in Hospital
Figure 16. Global FIC Drugs Market: Hospital (2021-2026) & (K Units)
Figure 17. FIC Drugs Consumed in Clinic
Figure 18. Global FIC Drugs Market: Clinic (2021-2026) & (K Units)
Figure 19. FIC Drugs Consumed in Other
Figure 20. Global FIC Drugs Market: Other (2021-2026) & (K Units)
Figure 21. Global FIC Drugs Sale Market Share by Application (2025)
Figure 22. Global FIC Drugs Revenue Market Share by Application in 2026
Figure 23. FIC Drugs Sales by Company in 2026 (K Units)
Figure 24. Global FIC Drugs Sales Market Share by Company in 2026
Figure 25. FIC Drugs Revenue by Company in 2026 ($ millions)
Figure 26. Global FIC Drugs Revenue Market Share by Company in 2026
Figure 27. Global FIC Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global FIC Drugs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas FIC Drugs Sales 2021-2026 (K Units)
Figure 30. Americas FIC Drugs Revenue 2021-2026 ($ millions)
Figure 31. APAC FIC Drugs Sales 2021-2026 (K Units)
Figure 32. APAC FIC Drugs Revenue 2021-2026 ($ millions)
Figure 33. Europe FIC Drugs Sales 2021-2026 (K Units)
Figure 34. Europe FIC Drugs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa FIC Drugs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa FIC Drugs Revenue 2021-2026 ($ millions)
Figure 37. Americas FIC Drugs Sales Market Share by Country in 2026
Figure 38. Americas FIC Drugs Revenue Market Share by Country (2021-2026)
Figure 39. Americas FIC Drugs Sales Market Share by Type (2021-2026)
Figure 40. Americas FIC Drugs Sales Market Share by Application (2021-2026)
Figure 41. United States FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC FIC Drugs Sales Market Share by Region in 2026
Figure 46. APAC FIC Drugs Revenue Market Share by Region (2021-2026)
Figure 47. APAC FIC Drugs Sales Market Share by Type (2021-2026)
Figure 48. APAC FIC Drugs Sales Market Share by Application (2021-2026)
Figure 49. China FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. India FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe FIC Drugs Sales Market Share by Country in 2026
Figure 57. Europe FIC Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Europe FIC Drugs Sales Market Share by Type (2021-2026)
Figure 59. Europe FIC Drugs Sales Market Share by Application (2021-2026)
Figure 60. Germany FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. France FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa FIC Drugs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa FIC Drugs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa FIC Drugs Sales Market Share by Application (2021-2026)
Figure 68. Egypt FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of FIC Drugs in 2026
Figure 74. Manufacturing Process Analysis of FIC Drugs
Figure 75. Industry Chain Structure of FIC Drugs
Figure 76. Channels of Distribution
Figure 77. Global FIC Drugs Sales Market Forecast by Region (2027-2032)
Figure 78. Global FIC Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global FIC Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global FIC Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global FIC Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global FIC Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of FIC Drugs
Figure 2. FIC Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global FIC Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global FIC Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. FIC Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. FIC Drugs Sales Market Share by Country/Region (2025)
Figure 10. FIC Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of FIC Single-target Drugs
Figure 12. Product Picture of FIC Dual-target Drugs
Figure 13. Global FIC Drugs Sales Market Share by Type in 2026
Figure 14. Global FIC Drugs Revenue Market Share by Type (2021-2026)
Figure 15. FIC Drugs Consumed in Hospital
Figure 16. Global FIC Drugs Market: Hospital (2021-2026) & (K Units)
Figure 17. FIC Drugs Consumed in Clinic
Figure 18. Global FIC Drugs Market: Clinic (2021-2026) & (K Units)
Figure 19. FIC Drugs Consumed in Other
Figure 20. Global FIC Drugs Market: Other (2021-2026) & (K Units)
Figure 21. Global FIC Drugs Sale Market Share by Application (2025)
Figure 22. Global FIC Drugs Revenue Market Share by Application in 2026
Figure 23. FIC Drugs Sales by Company in 2026 (K Units)
Figure 24. Global FIC Drugs Sales Market Share by Company in 2026
Figure 25. FIC Drugs Revenue by Company in 2026 ($ millions)
Figure 26. Global FIC Drugs Revenue Market Share by Company in 2026
Figure 27. Global FIC Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global FIC Drugs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas FIC Drugs Sales 2021-2026 (K Units)
Figure 30. Americas FIC Drugs Revenue 2021-2026 ($ millions)
Figure 31. APAC FIC Drugs Sales 2021-2026 (K Units)
Figure 32. APAC FIC Drugs Revenue 2021-2026 ($ millions)
Figure 33. Europe FIC Drugs Sales 2021-2026 (K Units)
Figure 34. Europe FIC Drugs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa FIC Drugs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa FIC Drugs Revenue 2021-2026 ($ millions)
Figure 37. Americas FIC Drugs Sales Market Share by Country in 2026
Figure 38. Americas FIC Drugs Revenue Market Share by Country (2021-2026)
Figure 39. Americas FIC Drugs Sales Market Share by Type (2021-2026)
Figure 40. Americas FIC Drugs Sales Market Share by Application (2021-2026)
Figure 41. United States FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC FIC Drugs Sales Market Share by Region in 2026
Figure 46. APAC FIC Drugs Revenue Market Share by Region (2021-2026)
Figure 47. APAC FIC Drugs Sales Market Share by Type (2021-2026)
Figure 48. APAC FIC Drugs Sales Market Share by Application (2021-2026)
Figure 49. China FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. India FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe FIC Drugs Sales Market Share by Country in 2026
Figure 57. Europe FIC Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Europe FIC Drugs Sales Market Share by Type (2021-2026)
Figure 59. Europe FIC Drugs Sales Market Share by Application (2021-2026)
Figure 60. Germany FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. France FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa FIC Drugs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa FIC Drugs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa FIC Drugs Sales Market Share by Application (2021-2026)
Figure 68. Egypt FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries FIC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of FIC Drugs in 2026
Figure 74. Manufacturing Process Analysis of FIC Drugs
Figure 75. Industry Chain Structure of FIC Drugs
Figure 76. Channels of Distribution
Figure 77. Global FIC Drugs Sales Market Forecast by Region (2027-2032)
Figure 78. Global FIC Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global FIC Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global FIC Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global FIC Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global FIC Drugs Revenue Market Share Forecast by Application (2027-2032)
